Efficacy and safety of Omalizumab in the treatment of CSU: a meta-analysis of a randomized controlled trial.

Saved in:
Bibliographic Details
Title: Efficacy and safety of Omalizumab in the treatment of CSU: a meta-analysis of a randomized controlled trial.
Authors: Zhang W; Department of Dematology, Wuhai People's Hospital, No.29 Huanghe East Street, Wuhai, People's Republic of China., Cao X; Department of Dematology, Bayannur Hospital, No.58 Wulanbuhe Road, Inner Mongolia Autonomous Region, Linhe, 015000, China., Liu L; Department of Dematology, Wuhai People's Hospital, No.29 Huanghe East Street, Wuhai, People's Republic of China. 1009172997@qq.com.; Department of Dematology, Bayannur Hospital, No.58 Wulanbuhe Road, Inner Mongolia Autonomous Region, Linhe, 015000, China. 1009172997@qq.com.
Source: Archives of dermatological research [Arch Dermatol Res] 2025 May 29; Vol. 317 (1), pp. 785. Date of Electronic Publication: 2025 May 29.
Publication Type: Journal Article; Meta-Analysis
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-069X
DOI:10.1007/s00403-025-04283-y